On the Dynamics of HIV-Tuberculosis Coinfection Model with Temporal Recovery from Tuberculosis: An Analysis
Pankaj Singh Rana1,2, Nitin Sharma1, Sunil Singh Negi1
1Department of Mathematics, National Institute of Technology, Uttarakhand, India.
Summary
This study models HIV-TB coinfection, finding TB treatment is most effective when the coinfection rate is low. Reinfection with TB significantly complicates disease eradication efforts.
Area of Science:
- Epidemiology
- Mathematical Biology
- Infectious Disease Modeling
Background:
- HIV and Tuberculosis (TB) are significant global health challenges.
- Coinfection with HIV and TB presents complex transmission dynamics and treatment difficulties.
- Understanding the interplay between HIV and TB is crucial for effective public health interventions.
Purpose of the Study:
- To develop a deterministic compartmental model for HIV-TB coinfection.
- To analyze the impact of TB reinfection on disease transmission and eradication.
- To evaluate the effectiveness of TB treatment strategies in the context of coinfection.
Main Methods:
- Constructed a composite model integrating an SI-type HIV model with an SEIR-type TB model.
- Performed qualitative analysis, including equilibrium point determination and basic reproduction number calculation.
- Utilized numerical simulations to investigate treatment effects and the influence of TB reinfection.
Main Results:
- The model predicts an interior equilibrium when both HIV and TB reproduction numbers exceed unity.
- TB treatment is most effective in eliminating coinfection when the basic reproduction number of HIV-TB is less than one.
- TB reinfection after recovery was found to increase overall transmission and hinder disease eradication.
Conclusions:
- The developed mathematical model provides insights into HIV-TB coinfection dynamics.
- TB reinfection poses a significant challenge to eradicating HIV-TB coinfection.
- Targeted treatment strategies, considering reinfection, are essential for managing HIV-TB coinfection.
Related Concept Videos
Pulmonary Tuberculosis II
201
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
201
Pulmonary Tuberculosis I
208
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
208
Pulmonary Tuberculosis V
155
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
155
Retrovirus Life Cycles
45.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
Pulmonary Tuberculosis IV
123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
Pulmonary Tuberculosis III
267
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
267


